-
Pfizer and Novartis Could Be Eyeing Onyx (PFE, NVS, ONXX)
Tuesday, July 2, 2013 - 8:58am | 628Read More...Things are starting to heat up in the already hot pharmaceutical sector – especially as it relates to mergers and acquisitions. Only days after Onyx Pharmaceuticals (NASDAQ: ONXX) said it rejected an $8.7 billion buyout offer from Amgen (NASDAQ: AMGN), according to Reuters, the company has...
-
AstraZeneca (AZN) Settles Tax Dispute, Raises Forecast
Tuesday, February 23, 2010 - 7:38am | 95Read More...British health care company AstraZeneca Plc (NYSE: AZN) announced on Tuesday that it had reached an agreement with the U.K. Revenue & Customs agency over a pricing dispute. AstraZeneca agreed to pay 505 million pounds ($783 million) to settle the dispute. AstraZeneca will pay in two...
-
AstraZeneca (AZN) To Cut 10,400 Jobs
Thursday, January 28, 2010 - 1:20pm | 181Read More...Pharmaceutical giant AstraZeneca plc (NYSE: AZN) reported that the company will eliminate 10,400 jobs over the next four years. The Anglo-Swedish drug maker's recent returns have been quite strong and the company increased its dividend by 12% to $2.30 per share, but the coming years may see a...
